Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$92.98

-0.38 (-0.41%)

, AMD

AMD

$8.94

0.23 (2.64%)

08:23
11/22/16
11/22
08:23
11/22/16
08:23

MKM Partners raises NVIDIA, AMD price targets on inflecting semi opportunities

MKM Partners analyst Ian Ing raised his price target for NVIDIA (NVDA) to $106 from $87, saying that thematic attention is heating up as large suppliers are crowding into artificial intelligence as an investment theme with non-GPU solutions. While other suppliers may be able to come up with better performance-for-power in certain use cases, he believes NVIDIA GPUs still have user stickiness with developer incumbency and easy-to-use tools that will be difficult to overcome. The analyst also raised his price target for AMD (AMD) to $10.50 from $8 to reflect improved prospects for the company driven by new product pipeline. Although Ian expects AMD to be a relatively minor player, its shares are helped by continued A.I. headlines and NVIDIA, Intel (INTC), and Qualcomm (QCOM) turning increasingly vocal on the opportunity. He reiterates a Buy rating on NVIDIA and AMD shares.

NVDA

Nvidia

$92.98

-0.38 (-0.41%)

AMD

AMD

$8.94

0.23 (2.64%)

INTC

Intel

$34.98

0.03 (0.09%)

QCOM

Qualcomm

$67.10

-0.21 (-0.31%)

  • 22

    Nov

  • 28

    Nov

NVDA Nvidia
$92.98

-0.38 (-0.41%)

11/14/16
ROTH
11/14/16
NO CHANGE
Target $95
ROTH
Buy
NVIDIA price target raised to $95 from $73 at Roth Capital
Roth Capital analyst Brian Alger raised his price target for NVIDIA to $95 from $73 after the company reported another "truly incredible" quarterly update. The analyst reiterates a Buy rating on the shares.
11/14/16
NEED
11/14/16
UPGRADE
NEED
Buy
NVIDIA upgraded to Buy from Hold at Needham
11/11/16
RBCM
11/11/16
NO CHANGE
RBCM
NVIDIA price target raised to $95 from $80 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on NVIDIA after the company reported stronger than expected results. The analyst says the company had a "blow out quarter," and he thinks that the company's Deep Learning and Robotics businesses could enable it to grow rapidly. He thinks that the company's long-term growth will be strong, and he keeps an Outperform rating on the shares.
11/14/16
11/14/16
UPGRADE
Target $100

Buy
NVIDIA upgraded to Buy at Needham
As previously reported, Needham analyst Rajvindra Gill upgraded NVIDIA to Buy from Hold, with a $100 price target, after the company's "significant" beat and raise quarter. The analyst says his view is based on long-term secular trends, namely the incorporation of ADAS applications in automotive market and where NVIDIA's Drive PX2 supplies Level 3-5 autonomy, the proliferation of machine learning, AI and graphics virtualization in the data center, and the emergence of virtual reality devices in PC and gaming markets driving higher graphics content.
AMD AMD
$8.94

0.23 (2.64%)

10/21/16
ADAM
10/21/16
NO CHANGE
Target $9
ADAM
Buy
AMD weakness a buying opportunity, says Canaccord
Canaccord analyst Matthew Ramsay said AMD reported "solid" Q3 results and provided seasonally lower guidance, which was expected. The analyst said his buy thesis remains intact and the selloff in the after hours was unwarranted. Ramsay said the weakness in the shares is a buying opportunity with the risk/reward tilted toward the upside upon entering an important year for the company's turnaround. Ramsay reiterated his Buy rating and $8.50 price target on AMD shares.
10/21/16
BERN
10/21/16
NO CHANGE
BERN
AMD outlook 'sounds promising,' says Bernstein
Bernstein analyst Stacy Rasgon says that AMD's Q3 results were "strong," and the analyst says that the comments and evidence presented by the company about its design wins and engagements "sound promising." Rasgon says she's weary about AMD, given its past missteps, but the analyst admits that she "just might be warming up to the story." Rasgon raised her price target on the shares to $7.50 from $6 but keeps a Market Perform rating on the stock.
10/21/16
SBSH
10/21/16
NO CHANGE
Target $3.5
SBSH
Sell
AMD continues to lose money, says Citi
Citi analyst Christopher Danely keeps a Sell rating on AMD following the company's Q3 results. AMD continues to lose money despite improving fundamentals with estimated net debt of $353.3M, Danely tells investors in a research note. He raised his price target for the shares to $3.50 from $2.50.
10/19/16
10/19/16
NO CHANGE

Intel Q4 PC commentary negative for Marvell, others resilient says Pacific Crest
Pacific Crest notes that Intel (INTC) said its PC customers are poised to reduce their inventories in Q4. The firm says that the comment is negative for Marvell (MRVL). However, the firm believes that Advanced Micro Devices (AMD), NVIDIA (NVDA), ON Semiconductor (ON) and Synaptics (SYNA) are "most resilient" to this development, given their share gains, growth and other factors.
INTC Intel
$34.98

0.03 (0.09%)

10/19/16
10/19/16
NO CHANGE

Intel data center results bode badly for several stocks, says Pacific Crest
Pacific Crest says that Intel's (INTC) data center results and commentary were "modestly disappointing," as enterprise demand for the company's data center products was "weak," according to the firm. The firm thinks that the negative enterprise results are "modestly negative for stocks with enterprise exposure, including Micron (MU), Seagate (STX) and Western Digital (WDC)."
10/19/16
ROTH
10/19/16
NO CHANGE
Target $40
ROTH
Buy
Roth Capital cuts Intel price target after guidance disappoints
Roth Capital analyst Suji Desilva lowered his price target for Intel to $40 from $43 after disappointing guidance. However, the analyst expects the shares to recover with a reset of expectations. Desilva continues to be encouraged by the company's transition to growth areas such as cloud data center, networking and IoT, and by the stable margin profile. He reiterates a Buy rating on the shares.
10/19/16
BARD
10/19/16
NO CHANGE
Target $42
BARD
Outperform
Intel fundamentals improving despite server shortfall, says Baird
Baird analyst Tristan Gerra believes Intel will maintain its 40% market share in mobile resulting in a continued decline in its mobile losses in 2017. The analyst noted the company lowered its outlook for client data center groups, which could weigh on the shares for the remainder of the year. Gerra believes the longer-term fundamentals remain intact with a still rising DCG mix, stabilization in PC comps, and further reductions in mobile losses driving a sustainable resumption in earnings growth. Gerra reiterated his Outperform rating and $42 price target on Intel shares.
QCOM Qualcomm
$67.10

-0.21 (-0.31%)

11/01/16
11/01/16
DOWNGRADE

Sector Weight
NXP Semiconductors downgraded to Sector Weight from Overweight at Pacific Crest
Pacific Crest analyst John Vinh downgraded NXP Semiconductors (NXPI) to Sector Weight citing the pending takeover by Qualcomm (QCOM). The analyst does not anticipate other competing offers or any regulatory issues to block the deal.
11/10/16
11/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Comerica (CMA) downgraded to Neutral from Outperform at Baird with analyst David George saying he sees a more balanced risk/reward as the company is already getting significant credit for earnings leverage from its efficiency program. 2. Qualcomm (QCOM) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst James Faucette saying Qualcomm's valuation adequately reflects incremental smartphone opportunities and NXP Semiconductor (NXPI) contribution. 3. CSX (CSX) downgraded to Market Perform from Outperform at BMO Capital with analyst Fadi Chamoun saying the company will be hurt in the near-term by "an over-supplied trucking market," while its cost savings are expected to decelerate next year and macro economic trends will become less favorable to the company. 4. SolarEdge (SEDG) downgraded to Market Perform from Outperform at JMP Securities, to Market Perform from Outperform at FBR Capital, and to Neutral from Buy at Roth Capital. 5. Capitala Finance (CPTA) downgraded to Perform from Outperform at Oppenheimer and to Neutral from Buy at Ladenburg. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/10/16
11/10/16
DOWNGRADE
Target $65

Equal Weight
Qualcomm downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley downgraded Qualcomm (QCOM) to Equal Weight from Overweight. Analyst James Faucette said Qualcomm's valuation adequately reflects incremental smartphone opportunities and NXP Semiconductor (NXPI) contribution and maintained his $65 price target on shares.
11/10/16
MSCO
11/10/16
DOWNGRADE
MSCO
Equal Weight
Qualcomm downgraded to Equal Weight from Overweight at Morgan Stanley

TODAY'S FREE FLY STORIES

BAC

Bank of America

$31.18

-0.06 (-0.19%)

, GE

General Electric

$17.35

-0.86 (-4.72%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Options
Notable open interest changes for January 18th »

Wednesday's total…

BAC

Bank of America

$31.18

-0.06 (-0.19%)

GE

General Electric

$17.35

-0.86 (-4.72%)

FB

Facebook

$177.60

-0.79 (-0.44%)

BABA

Alibaba

$183.83

1.43 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 07

    Feb

  • 15

    Feb

  • 28

    Feb

08:55
01/18/18
01/18
08:55
01/18/18
08:55
General news
U.S. housing starts dropped 8.2% to 1.192 M in December »

U.S. housing starts…

ABM

ABM

$38.73

0.26 (0.68%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Conference/Events
ABM to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AMGP

Antero Midstream GP

$20.89

-0.11 (-0.52%)

, AM

Antero Midstream Partners

$30.95

-0.8 (-2.52%)

08:55
01/18/18
01/18
08:55
01/18/18
08:55
Conference/Events
Antero Resources to host analyst day »

Analyst Day to be held in…

AMGP

Antero Midstream GP

$20.89

-0.11 (-0.52%)

AM

Antero Midstream Partners

$30.95

-0.8 (-2.52%)

AR

Antero Resources

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

BIVV

Bioverativ

$62.32

-1.55 (-2.43%)

08:54
01/18/18
01/18
08:54
01/18/18
08:54
Initiation
Bioverativ initiated  »

Bioverativ assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 25

    Apr

UTHR

United Therapeutics

$140.32

5.2 (3.85%)

08:54
01/18/18
01/18
08:54
01/18/18
08:54
Initiation
United Therapeutics initiated  »

United Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$82.47

2.05 (2.55%)

08:53
01/18/18
01/18
08:53
01/18/18
08:53
Recommendations
PayPal analyst commentary  »

PayPal Q4 may see upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

EDGE

Edge Therapeutics

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Initiation
Edge Therapeutics initiated  »

Edge Therapeutics assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$90.14

1.79 (2.03%)

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 31

    Jan

  • 07

    Feb

SNAP

Snap

$13.52

0.02 (0.15%)

, FB

Facebook

$177.60

-0.79 (-0.44%)

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Conference/Events
SunTrust Internet & digital media analyst holds analyst/industry conference call »

Internet & Digital…

SNAP

Snap

$13.52

0.02 (0.15%)

FB

Facebook

$177.60

-0.79 (-0.44%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

TWTR

Twitter

$24.56

-0.1 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

BMRN

BioMarin

$89.64

-0.6 (-0.66%)

08:52
01/18/18
01/18
08:52
01/18/18
08:52
Initiation
BioMarin initiated  »

BioMarin assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 25

    May

LEN

Lennar

$70.71

1.93 (2.81%)

08:51
01/18/18
01/18
08:51
01/18/18
08:51
Upgrade
Lennar rating change  »

Lennar upgraded to Buy at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICBK

County Bancorp

$30.73

-1.57 (-4.86%)

08:51
01/18/18
01/18
08:51
01/18/18
08:51
Earnings
County Bancorp reports Q4 EPS 30c, consensus 47c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$34.40

0.64 (1.90%)

08:51
01/18/18
01/18
08:51
01/18/18
08:51
Upgrade
PulteGroup rating change  »

PulteGroup upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

AVXS

AveXis

$104.87

-0.14 (-0.13%)

08:50
01/18/18
01/18
08:50
01/18/18
08:50
Initiation
AveXis initiated  »

AveXis initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

MS

Morgan Stanley

$55.35

0.75 (1.37%)

08:50
01/18/18
01/18
08:50
01/18/18
08:50
Hot Stocks
Morgan Stanley CEO sees immediate positive impact from tax reform »

Sees meaningful reduction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

08:50
01/18/18
01/18
08:50
01/18/18
08:50
General news
U.S. Philly Fed's manufacturing index fell 5.7 points to 22.2 in January »

U.S. Philly Fed's…

IIPR

Innovative Industrial Properties

$31.30

-2.49 (-7.37%)

08:49
01/18/18
01/18
08:49
01/18/18
08:49
Syndicate
Innovative Industrial Properties 2.8M share Spot Secondary priced at $26.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MYOK

MyoKardia

$52.60

0.6 (1.15%)

08:49
01/18/18
01/18
08:49
01/18/18
08:49
Initiation
MyoKardia initiated  »

MyoKardia assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$47.77

1.96 (4.28%)

08:49
01/18/18
01/18
08:49
01/18/18
08:49
Initiation
Ultragenyx initiated  »

Ultragenyx initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

GSL

Global Ship Lease

$1.16

-0.05 (-4.13%)

08:48
01/18/18
01/18
08:48
01/18/18
08:48
Hot Stocks
Global Ship Lease engages Evercore to explore strategic alternatives »

Global Ship Lease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRML

Vermillion

$1.67

-0.04 (-2.34%)

08:48
01/18/18
01/18
08:48
01/18/18
08:48
Hot Stocks
Vermillion signs agreement for OVA1 test with BlueCross BlueShield of Illinois »

Vermillion company ASPiRA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$51.53

0.21 (0.41%)

08:47
01/18/18
01/18
08:47
01/18/18
08:47
Initiation
Spark Therapeutics initiated  »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

INSM

Insmed

$30.22

0.65 (2.20%)

08:47
01/18/18
01/18
08:47
01/18/18
08:47
Initiation
Insmed initiated  »

Insmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$75.84

3.93 (5.47%)

08:46
01/18/18
01/18
08:46
01/18/18
08:46
Initiation
Esperion initiated  »

Esperion initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.